RCT | Safety and efficacy of Liraglutide vs. Colesevelam for treating bile acid diarrhea.
26 Jul, 2022 | 12:29h | UTCSafety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary: Diabetes Drug for Bile Acid Diarrhea Bests Standard of Care in Small Trial — Liraglutide proves superior to colesevelam for cutting daily stool frequency in Danish trial – MedPage Today (free registration required)
Commentary on Twitter
New research – Kårhus et al – Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trialhttps://t.co/7Q69CcvjcJ#BAD #GITwitter @MKarhus @filip_Knop pic.twitter.com/lkfSLLgokO
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) July 20, 2022